Effect of a novel oral chemotherapeutic agent containing a combination of trifluridine, tipiracil and the novel triple angiokinase inhibitor nintedanib, on human colorectal cancer xenografts

Trifluridine/tipiracil (TFTD) is a combination drug that is used for the treatment of metastatic colorectal cancer and was formerly known as TAS-102. It is a combination of two active pharmaceutical compounds, trifluridine, an antineoplastic thymidine-based nucleoside analog, and tipiracil, which en...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Norihiko, Nakagawa, Fumio, Matsuoka, Kazuaki, Takechi, Teiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112602/
https://www.ncbi.nlm.nih.gov/pubmed/27805254
http://dx.doi.org/10.3892/or.2016.5208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112602/
https://www.ncbi.nlm.nih.gov/pubmed/27805254
http://dx.doi.org/10.3892/or.2016.5208

Ejemplares similares